Clinical Trial Update: Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT [Phase 2]

View source ↗

Summary

Phase 2 study evaluating reduced-intensity conditioning for non-malignant disorders undergoing umbilical cord blood transplantation (UCBT), bone marrow transpla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Bone Marrow Failure Syndromes
• Hereditary Anemias
• Immunodeficiency
• Inflammatory Diseases
• Inherited Metabolic Disorders
• Juvenile Idiopathic Arthritis
• Systemic Juvenile Idiopathic Arthritis

Snippet

Sponsor: Paul Szabolcs | Conditions: Primary Immunodeficiency (PID), Congenital Bone Marrow Failure Syndromes | Phase 2 | Status: RECRUITING